3'-O-tert-butyldimethylsilyl-2'-deoxy-5'-O-(sylfamoyl)adenosine | 862179-54-2

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 嘌呤核苷
• 英文名称: 3'-O-tert-butyldimethylsilyl-2'-deoxy-5'-O-(sylfamoyl)adenosine
• 英文别名: 3'-O-tert-butyldimethylsilyl-2'-deoxy-5'-O-(sulfamoyl)adenosine；[(2R,3S,5R)-5-(6-aminopurin-9-yl)-3-[tert-butyl(dimethyl)silyl]oxyoxolan-2-yl]methyl sulfamate
• CAS: 862179-54-2
• 化学式: C₁₆H₂₈N₆O₅SSi
• 分子量: 444.587
• InChiKey: ATKBWPRSKUXXBL-QJPTWQEYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.31
• 重原子数：
  29
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.69
• 拓扑面积：
  166
• 氢给体数：
  2
• 氢受体数：
  10

反应信息

• 作为反应物：
  描述：

  3'-O-tert-butyldimethylsilyl-2'-deoxy-5'-O-(sylfamoyl)adenosine 在 sodium hydride 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 作用下， 以 乙二醇二甲醚 、 N,N-二甲基甲酰胺 为溶剂， 反应 32.5h， 生成 5'-O-(N-(2-benzyloxybenzoyl)sulfamoyl)-2'-O-tert-butyldimethylsilyl-3'-deoxyadenosine
  参考文献：
  名称：

  Antitubercular Nucleosides That Inhibit Siderophore Biosynthesis:  SAR of the Glycosyl Domain

  摘要：

  Tuberculosis is the leading cause of infectious disease mortality in the world by a bacterial pathogen. We previously demonstrated that a bisubstrate inhibitor of the adenylation enzyme MbtA, which is responsible for the second step of mycobactin biosynthesis, exhibited potent antitubercular activity. Here we systematically investigate the structure-activity relationships of the bisubstrate inhibitor glycosyl domain resulting in the identification of a carbocyclic analogue that possesses a K-I(app) value of 2.3 nM and MIC99 values of 1.56 mu M against M. tuberculosis H37Rv. The SAR data suggest the intriguing possibility that the bisubstrate inhibitors utilize a transporter for entry across the mycobacterial cell envelope. Additionally, we report improved conditions for the expression of MbtA and biochemical analysis, demonstrating that MbtA follows a random sequential enzyme mechanism for the adenylation half-reaction.

  DOI：

  10.1021/jm061068d
• 作为产物：
  描述：

  2'-脱氧腺苷 在 palladium on activated charcoal 咪唑 、 氢气 、 溶剂黄146 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 生成 3'-O-tert-butyldimethylsilyl-2'-deoxy-5'-O-(sylfamoyl)adenosine
  参考文献：
  名称：

  甲硫酰基和异亮氨酰氨基磺酸的腺苷酸的脱氧核糖基类似物，作为甲硫酰基-tRNA和异亮氨酰-tRNA合成酶的抑制剂。

  摘要：

  已经研究了异亮氨酰和甲硫氨酸氨基磺酸腺苷酸的2'-脱氧，3'-脱氧和2'，3'-二脱氧核糖基替代物，以鉴定核糖基团对抑制大肠杆菌甲硫氨酸-tRNA（MRS）和异亮氨酰-tRNA（IRS）合成酶。具有大肠杆菌MRS晶体结构的2'，3'-二脱氧核糖基Met-NHSO2-AMP（9）的分子模型表明，核糖之间缺少两个氢键可弥补核糖上两个羟基的缺乏环氧和His24，导致活性降低较小。

  DOI：

  10.1016/j.bmcl.2005.05.035

文献信息

• Deoxyribosyl analogues of methionyl and isoleucyl sulfamate adenylates as inhibitors of methionyl-tRNA and isoleucyl-tRNA synthetases
  作者：Sung Eun Kim、Su Yeon Kim、Sunghoon Kim、Taehee Kang、Jeewoo Lee

  DOI：10.1016/j.bmcl.2005.05.035

  日期：2005.7

  2'-Deoxy, 3'-deoxy, and 2',3'-dideoxyribosyl surrogates of isoleucyl and methionyl sulfamate adenylates have been investigated to identify the pharmacophoric importance of the ribose group for the inhibition of Escherichia coli methionyl-tRNA (MRS) and isoleucyl-tRNA (IRS) synthetases. Molecular modeling of 2',3'-dideoxyribosyl Met-NHSO2-AMP (9) with the crystal structure of E. coli MRS revealed that

  已经研究了异亮氨酰和甲硫氨酸氨基磺酸腺苷酸的2'-脱氧，3'-脱氧和2'，3'-二脱氧核糖基替代物，以鉴定核糖基团对抑制大肠杆菌甲硫氨酸-tRNA（MRS）和异亮氨酰-tRNA（IRS）合成酶。具有大肠杆菌MRS晶体结构的2'，3'-二脱氧核糖基Met-NHSO2-AMP（9）的分子模型表明，核糖之间缺少两个氢键可弥补核糖上两个羟基的缺乏环氧和His24，导致活性降低较小。
• Antitubercular Nucleosides That Inhibit Siderophore Biosynthesis:  SAR of the Glycosyl Domain
  作者：Ravindranadh V. Somu、Daniel J. Wilson、Eric M. Bennett、Helena I. Boshoff、Laura Celia、Brian J. Beck、Clifton E. Barry、Courtney C. Aldrich

  DOI：10.1021/jm061068d

  日期：2006.12.1

  Tuberculosis is the leading cause of infectious disease mortality in the world by a bacterial pathogen. We previously demonstrated that a bisubstrate inhibitor of the adenylation enzyme MbtA, which is responsible for the second step of mycobactin biosynthesis, exhibited potent antitubercular activity. Here we systematically investigate the structure-activity relationships of the bisubstrate inhibitor glycosyl domain resulting in the identification of a carbocyclic analogue that possesses a K-I(app) value of 2.3 nM and MIC99 values of 1.56 mu M against M. tuberculosis H37Rv. The SAR data suggest the intriguing possibility that the bisubstrate inhibitors utilize a transporter for entry across the mycobacterial cell envelope. Additionally, we report improved conditions for the expression of MbtA and biochemical analysis, demonstrating that MbtA follows a random sequential enzyme mechanism for the adenylation half-reaction.